HO Bio Institute, Tokyo, Japan.
Department of Biochemistry, Meiji Pharmaceutical University, Tokyo, Japan.
J Antibiot (Tokyo). 2021 Jan;74(1):24-41. doi: 10.1038/s41429-020-0344-z. Epub 2020 Jul 9.
Antibiotic resistance is a global threat that should be urgently resolved. Finding a new antibiotic is one way, whereas the repression of the dissemination of virulent pathogenic bacteria is another. From this point of view, this paper summarizes first the mechanisms of conjugation and transformation, two important processes of horizontal gene transfer, and then discusses the approaches for disarming virulent pathogenic bacteria, that is, virulence factor inhibitors. In contrast to antibiotics, anti-virulence drugs do not impose a high selective pressure on a bacterial population, and repress the dissemination of antibiotic resistance and virulence genes. Disarmed virulence factors make virulent pathogens avirulent bacteria or pathobionts, so that we human will be able to coexist with these disarmed bacteria peacefully.
抗生素耐药性是一个全球性的威胁,应该紧急解决。寻找新的抗生素是一种方法,而抑制毒力病原菌的传播则是另一种方法。从这个角度来看,本文首先总结了接合和转化两种重要的水平基因转移过程的机制,然后讨论了使毒力病原菌失去毒力的方法,即毒力因子抑制剂。与抗生素不同,抗毒力药物不会对细菌种群施加高选择性压力,并且可以抑制抗生素耐药性和毒力基因的传播。去毒力的毒力因子使毒力病原菌变为无毒或条件致病菌,从而使我们人类能够与这些去毒力的细菌和平共处。